Miyamoto H - Search Results

1

[A case of primary orbital chondrosarcoma].

Miyamoto H, Yoshii M, Murakami A, Okisaka S, Miyatani S, Tanabe T, Karaho T, Inoue T, Kaji T, Tamai S. Miyamoto H, et al. Nippon Ganka Gakkai Zasshi. 1997 Feb;101(2):192-6. Nippon Ganka Gakkai Zasshi. 1997. PMID: 9124103 Japanese.

2

Effects of fluorescent light on growth of bovine retinal pigment epithelial cells in vitro incubated with linoleic acid or linoleic acid hydroperoxide.

Akeo K, Miyamoto H, Okisaka S, Hiramitsu T. Akeo K, et al. Among authors: miyamoto h. Pigment Cell Res. 1999 Jun;12(3):199-205. doi: 10.1111/j.1600-0749.1999.tb00514.x. Pigment Cell Res. 1999. PMID: 10385917

3

[Hyperbaric oxygen treatment for macular edema after retinal vein occlusion--fluorescein angiographic findings and visual prognosis].

Miyamoto H, Ogura Y, Honda Y. Miyamoto H, et al. Nippon Ganka Gakkai Zasshi. 1995 Feb;99(2):220-5. Nippon Ganka Gakkai Zasshi. 1995. PMID: 7701995 Japanese.

4

[The long term results of hyperbaric oxygen treatment for macular edema with retinal vein occlusion].

Miyamoto H, Ogura Y, Wakano Y, Honda Y. Miyamoto H, et al. Nippon Ganka Gakkai Zasshi. 1993 Sep;97(9):1065-9. Nippon Ganka Gakkai Zasshi. 1993. PMID: 8213366 Japanese.

5

Long-term outcome after radiation therapy for subfoveal choroidal neovascularization associated with age-related macular degeneration.

Mandai M, Takahashi M, Miyamoto H, Hiroshiba N, Kimura H, Ogura Y, Honda Y, Sasai K. Mandai M, et al. Among authors: miyamoto h. Jpn J Ophthalmol. 2000 Sep-Oct;44(5):530-7. doi: 10.1016/s0021-5155(00)00217-3. Jpn J Ophthalmol. 2000. PMID: 11033133

6

Biodegradable scleral implant for intravitreal controlled release of fluconazole.

Miyamoto H, Ogura Y, Hashizoe M, Kunou N, Honda Y, Ikada Y. Miyamoto H, et al. Curr Eye Res. 1997 Sep;16(9):930-5. doi: 10.1076/ceyr.16.9.930.5042. Curr Eye Res. 1997. PMID: 9288455

7

Effect of focal X-ray irradiation on experimental choroidal neovascularization.

Miyamoto H, Kimura H, Yasukawa T, Honda Y, Tabata Y, Ikada Y, Sasai K, Ogura Y. Miyamoto H, et al. Invest Ophthalmol Vis Sci. 1999 Jun;40(7):1496-502. Invest Ophthalmol Vis Sci. 1999. PMID: 10359332

8

Suppression of experimental corneal angiogenesis by focal X-ray irradiation.

Miyamoto H, Kimura H, Yasukawa T, Yang CF, Honda Y, Tabata Y, Ikada Y, Sasai K, Ogura Y. Miyamoto H, et al. Curr Eye Res. 1999 Jul;19(1):53-8. doi: 10.1076/ceyr.19.1.53.5338. Curr Eye Res. 1999. PMID: 10415457

9

Sustained release of cis-hydroxyproline in the treatment of experimental proliferative vitreoretinopathy in rabbits.

Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ogura Y. Yasukawa T, et al. Among authors: miyamoto h. Graefes Arch Clin Exp Ophthalmol. 2002 Aug;240(8):672-8. doi: 10.1007/s00417-002-0484-9. Epub 2002 Jul 12. Graefes Arch Clin Exp Ophthalmol. 2002. PMID: 12192462

10

Targeted delivery of anti-angiogenic agent TNP-470 using water-soluble polymer in the treatment of choroidal neovascularization.

Yasukawa T, Kimura H, Tabata Y, Miyamoto H, Honda Y, Ikada Y, Ogura Y. Yasukawa T, et al. Among authors: miyamoto h. Invest Ophthalmol Vis Sci. 1999 Oct;40(11):2690-6. Invest Ophthalmol Vis Sci. 1999. PMID: 10509667

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,920 results

Search Page

Filters